Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 113 JPY -0.19% Market Closed
Market Cap: 6.5T JPY
Have any thoughts about
Takeda Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Takeda Pharmaceutical Co Ltd stock under the Base Case scenario is 6 531.5 JPY. Compared to the current market price of 4 113 JPY, Takeda Pharmaceutical Co Ltd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6 531.5 JPY
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
60
Median 3Y
1.6
Median 5Y
1.6
Industry
2.5
Forward
1.5
vs History
74
vs Industry
9
Median 3Y
23.9
Median 5Y
28.5
Industry
21.9
Forward
52.7
vs History
33
vs Industry
37
Median 3Y
6.8
Median 5Y
6.9
Industry
16.5
vs History
50
vs Industry
2
Median 3Y
10.7
Median 5Y
7.3
Industry
23.6
vs History
65
vs Industry
64
Median 3Y
0.9
Median 5Y
1
Industry
2.1
vs History
98
vs Industry
43
Median 3Y
2.5
Median 5Y
2.6
Industry
2.6
Forward
2.3
vs History
95
vs Industry
50
Median 3Y
3.7
Median 5Y
3.8
Industry
5.2
vs History
82
vs Industry
31
Median 3Y
8.9
Median 5Y
9.2
Industry
13.3
Forward
8.5
vs History
79
vs Industry
8
Median 3Y
21.1
Median 5Y
23.5
Industry
16.6
Forward
44
vs History
42
vs Industry
27
Median 3Y
10.6
Median 5Y
11.1
Industry
15.6
vs History
44
vs Industry
10
Median 3Y
11.8
Median 5Y
18.2
Industry
19.1
vs History
55
vs Industry
65
Median 3Y
0.8
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Takeda Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Takeda Pharmaceutical Co Ltd
TSE:4502
6.5T JPY 1.4 22.5 7.7 18.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Takeda Pharmaceutical Co Ltd
TSE:4502
Average P/E: 31.2
22.5
107%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top